A comparison between Pfizer/BioNTech’s and Sinopharm’s SARS-CoV-2 vaccines

By | October 25, 2021
Researchers compare antibody titers elicited the Pfizer‐BioNTech mRNA and the classic inactivated virus Sinopharm vaccines.